United States Biotechnology & Medical Research

Cadrenal Therapeutics Inc (CVKD)

Cadrenal Therapeutics Inc. experienced multiple planned divestments by Chairman and CEO Pham Quang X throughout June 2026. These transactions concluded on June 29, 2026. No further insider trading activity has been recorded since that period, indicating a cessation of selling patterns by company leadership over the last three months.
Ticker: CVKD Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Cadrenal Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.8
Pham Quang X Chairman and CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
371.64
Quantity 38,296 +37.2%
Value US$4,080,334
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
313.67
Quantity 80,659 +18.4%
Value US$4,866,368
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
30.94
Quantity 8,107 +41.2%
Value US$200,189
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
3.20
Quantity 2,277 -1.9%
Value US$7,286
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
3.55
Quantity 9,167 -7.1%
Value US$32,543
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
3.16
Quantity 513 -0.4%
Value US$1,621
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
3.18
Quantity 3,613 -2.7%
Value US$11,489
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
3.58
Quantity 3,666 -2.7%
Value US$13,124
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
3.71
Quantity 40,000
Value US$148,400
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
3.94
Quantity 12,996 -8.7%
Value US$51,204
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
4.12
Quantity 1,462 -1.0%
Value US$6,023
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
4.21
Quantity 3,500 -2.3%
Value US$14,735
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
4.21
Quantity 3,500 -2.3%
Value US$14,735
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
4.06
Quantity 12,992 -7.8%
Value US$52,748
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
4.06
Quantity 12,992 -7.8%
Value US$52,748
2.8
Pham Quang X Chairman, CEO and Interim CFO Executive Director Large shareholder
Transaction date
Planned sale
Price
4.38
Quantity 5,893 -3.4%
Value US$25,811
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
4.42
Quantity 2,064 -1.2%
Value US$9,123
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
4.41
Quantity 3,898 -2.2%
Value US$17,190
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
4.26
Quantity 2,323 -1.3%
Value US$9,896
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
4.46
Quantity 349 -0.2%
Value US$1,557
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
5.01
Quantity 303 -0.2%
Value US$1,518
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
4.93
Quantity 2,989 -1.6%
Value US$14,736
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
5.69
Quantity 1,165 -0.6%
Value US$6,629
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
5.28
Quantity 3,298 -1.8%
Value US$17,413
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
5.76
Quantity 6,476 -3.3%
Value US$37,302
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
5.81
Quantity 60,000
Value US$348,600
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
6.97
Quantity 9,933 -100.0%
Value US$69,233
2.3
MATTHEW K SZOT Officer Officer
Transaction date
Proposed sale
Price
7.41
Quantity 9,933
Value US$73,604
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.99
Quantity 1,800 -15.3%
Value US$25,182
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
13.99
Quantity 1,315 -0.7%
Value US$18,397
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
14.13
Quantity 1,800
Value US$25,442
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
13.99
Quantity 1,315
Value US$18,397
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.99
Quantity 1,800 -13.3%
Value US$25,182
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
14.03
Quantity 1,129 -0.6%
Value US$15,840
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.77
Quantity 1,800
Value US$24,786
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.03
Quantity 1,129
Value US$15,841
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.62
Quantity 1,800
Value US$24,516
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.15
Quantity 1,800
Value US$25,470
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
14.15
Quantity 1,800 -0.9%
Value US$25,470
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
14.07
Quantity 1,800 -11.7%
Value US$25,326
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
14.02
Quantity 1,800 -0.9%
Value US$25,236
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.99
Quantity 1,693 -9.9%
Value US$23,685
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.96
Quantity 1,693
Value US$23,634
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.02
Quantity 1,800
Value US$25,228
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.99
Quantity 107 -0.6%
Value US$1,497
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
14.18
Quantity 107
Value US$1,517
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
14.13
Quantity 500 -0.2%
Value US$7,065
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.13
Quantity 500
Value US$7,066
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.83
Quantity 1,700
Value US$23,511
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.01
Quantity 881
Value US$12,343
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
14.01
Quantity 881 -0.4%
Value US$12,343
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.99
Quantity 1,700 -9.0%
Value US$23,783
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Planned sale
Price
14.01
Quantity 419 -0.2%
Value US$5,870
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Planned sale
Price
14.00
Quantity 100 -0.5%
Value US$1,400
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
14.03
Quantity 100
Value US$1,403
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.01
Quantity 419
Value US$5,870
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.09
Quantity 6,790
Value US$95,662
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Sale
Price
14.09
Quantity 6,790 -3.2%
Value US$95,671
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Sale
Price
14.05
Quantity 10,900 -36.5%
Value US$153,182
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.78
Quantity 10,900
Value US$150,202
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Sale
Price
13.99
Quantity 2,581 -1.2%
Value US$36,108
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Sale
Price
14.00
Quantity 1,500 -4.8%
Value US$20,993
2.8
Quang X. Pham Officer Officer
Transaction date
Proposed sale
Price
14.09
Quantity 6,790
Value US$95,662
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.68
Quantity 1,500
Value US$20,520
2.8
Quang Pham Officer Officer
Transaction date
Proposed sale
Price
13.99
Quantity 2,581
Value US$36,108
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Sale
Price
13.99
Quantity 1,193 -0.6%
Value US$16,690
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Sale
Price
14.00
Quantity 400 -1.3%
Value US$5,600
2.8
Pham Quang X Officer Officer
Transaction date
Proposed sale
Price
13.86
Quantity 1,193
Value US$16,541
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.93
Quantity 400
Value US$5,572
2.8
Pham Quang X CEO and Chairman Executive Director Large shareholder
Transaction date
Sale
Price
13.99
Quantity 3,836 -1.8%
Value US$53,666
2.3
Szot Matthew K Chief Financial Officer Officer
Transaction date
Sale
Price
14.00
Quantity 1,600 -4.8%
Value US$22,392
2.8
Pham Quang X Officer Officer
Transaction date
Proposed sale
Price
13.94
Quantity 3,836
Value US$53,456
2.8
Pham Quang X Officer Officer
Transaction date
Proposed sale
Price
13.99
Quantity 30,600
Value US$428,094
2.3
MATTHEW SZOT Officer Officer
Transaction date
Proposed sale
Price
13.75
Quantity 1,600
Value US$22,000
2.8
MURPHY JOHN RAYMOND Non-Executive Director
Transaction date
Purchase
Price
0.69
Quantity 2,669 +0.4%
Value US$1,842
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-01 2026-06-29 PlS Planned sale
2.8
Pham Quang X

Chairman and CEO

Executive Director Large shareholder
38,296 +37.2%
371.64
US$4,080,334 		38,296 +37.2% 371.64 US$4,080,334
2026-06-26 2026-06-26 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
80,659 +18.4%
313.67
US$4,866,368 		80,659 +18.4% 313.67 US$4,866,368
2026-06-26 2026-06-25 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
8,107 +41.2%
30.94
US$200,189 		8,107 +41.2% 30.94 US$200,189
2026-06-24 2026-06-23 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
2,277 -1.9%
3.20
US$7,286 		2,277 -1.9% 3.20 US$7,286
2026-06-24 2026-06-22 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
9,167 -7.1%
3.55
US$32,543 		9,167 -7.1% 3.55 US$32,543
2026-06-18 2026-06-17 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
513 -0.4%
3.16
US$1,621 		513 -0.4% 3.16 US$1,621
2026-06-18 2026-06-16 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
3,613 -2.7%
3.18
US$11,489 		3,613 -2.7% 3.18 US$11,489
2026-06-15 2026-06-15 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
3,666 -2.7%
3.58
US$13,124 		3,666 -2.7% 3.58 US$13,124
2026-06-15 2026-06-15 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
40,000
3.71
US$148,400 		40,000 3.71 US$148,400
2026-06-15 2026-06-12 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
12,996 -8.7%
3.94
US$51,204 		12,996 -8.7% 3.94 US$51,204
2026-06-15 2026-06-11 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
1,462 -1.0%
4.12
US$6,023 		1,462 -1.0% 4.12 US$6,023
2026-06-10 2026-06-10 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
3,500 -2.3%
4.21
US$14,735 		3,500 -2.3% 4.21 US$14,735
2026-06-10 2026-06-10 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
3,500 -2.3%
4.21
US$14,735 		3,500 -2.3% 4.21 US$14,735
2026-06-10 2026-06-09 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
12,992 -7.8%
4.06
US$52,748 		12,992 -7.8% 4.06 US$52,748
2026-06-10 2026-06-09 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
12,992 -7.8%
4.06
US$52,748 		12,992 -7.8% 4.06 US$52,748
2026-06-10 2026-06-08 PlS Planned sale
2.8
Pham Quang X

Chairman, CEO and Interim CFO

Executive Director Large shareholder
5,893 -3.4%
4.38
US$25,811 		5,893 -3.4% 4.38 US$25,811
2026-06-05 2026-06-05 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
2,064 -1.2%
4.42
US$9,123 		2,064 -1.2% 4.42 US$9,123
2026-06-05 2026-06-04 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
3,898 -2.2%
4.41
US$17,190 		3,898 -2.2% 4.41 US$17,190
2026-06-05 2026-06-03 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
2,323 -1.3%
4.26
US$9,896 		2,323 -1.3% 4.26 US$9,896
2026-06-02 2026-06-02 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
349 -0.2%
4.46
US$1,557 		349 -0.2% 4.46 US$1,557
2026-06-02 2026-05-29 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
303 -0.2%
5.01
US$1,518 		303 -0.2% 5.01 US$1,518
2026-05-29 2026-05-28 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
2,989 -1.6%
4.93
US$14,736 		2,989 -1.6% 4.93 US$14,736
2026-05-26 2026-05-22 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
1,165 -0.6%
5.69
US$6,629 		1,165 -0.6% 5.69 US$6,629
2026-05-29 2026-05-12 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
3,298 -1.8%
5.28
US$17,413 		3,298 -1.8% 5.28 US$17,413
2026-05-29 2026-05-11 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
6,476 -3.3%
5.76
US$37,302 		6,476 -3.3% 5.76 US$37,302
2026-05-11 2026-05-11 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
60,000
5.81
US$348,600 		60,000 5.81 US$348,600
2025-12-31 2025-12-29 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
9,933 -100.0%
6.97
US$69,233 		9,933 -100.0% 6.97 US$69,233
2025-12-29 2025-12-29 PrS Proposed sale
2.3
MATTHEW K SZOT

Officer

Officer
9,933
7.41
US$73,604 		9,933 7.41 US$73,604
2025-10-28 2025-10-27 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
1,800 -15.3%
13.99
US$25,182 		1,800 -15.3% 13.99 US$25,182
2025-10-28 2025-10-27 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
1,315 -0.7%
13.99
US$18,397 		1,315 -0.7% 13.99 US$18,397
2025-10-27 2025-10-27 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
1,800
14.13
US$25,442 		1,800 14.13 US$25,442
2025-10-27 2025-10-27 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
1,315
13.99
US$18,397 		1,315 13.99 US$18,397
2025-10-28 2025-10-24 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
1,800 -13.3%
13.99
US$25,182 		1,800 -13.3% 13.99 US$25,182
2025-10-28 2025-10-24 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
1,129 -0.6%
14.03
US$15,840 		1,129 -0.6% 14.03 US$15,840
2025-10-24 2025-10-24 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
1,800
13.77
US$24,786 		1,800 13.77 US$24,786
2025-10-24 2025-10-24 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
1,129
14.03
US$15,841 		1,129 14.03 US$15,841
2025-10-14 2025-10-13 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
1,800
13.62
US$24,516 		1,800 13.62 US$24,516
2025-10-14 2025-10-13 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
1,800
14.15
US$25,470 		1,800 14.15 US$25,470
2025-10-14 2025-10-13 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
1,800 -0.9%
14.15
US$25,470 		1,800 -0.9% 14.15 US$25,470
2025-10-14 2025-10-13 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
1,800 -11.7%
14.07
US$25,326 		1,800 -11.7% 14.07 US$25,326
2025-10-14 2025-10-09 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
1,800 -0.9%
14.02
US$25,236 		1,800 -0.9% 14.02 US$25,236
2025-10-14 2025-10-09 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
1,693 -9.9%
13.99
US$23,685 		1,693 -9.9% 13.99 US$23,685
2025-10-09 2025-10-09 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
1,693
13.96
US$23,634 		1,693 13.96 US$23,634
2025-10-09 2025-10-09 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
1,800
14.02
US$25,228 		1,800 14.02 US$25,228
2025-10-07 2025-10-06 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
107 -0.6%
13.99
US$1,497 		107 -0.6% 13.99 US$1,497
2025-10-06 2025-10-06 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
107
14.18
US$1,517 		107 14.18 US$1,517
2025-10-03 2025-10-02 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
500 -0.2%
14.13
US$7,065 		500 -0.2% 14.13 US$7,065
2025-10-02 2025-10-02 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
500
14.13
US$7,066 		500 14.13 US$7,066
2025-10-01 2025-10-01 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
1,700
13.83
US$23,511 		1,700 13.83 US$23,511
2025-10-01 2025-10-01 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
881
14.01
US$12,343 		881 14.01 US$12,343
2025-10-01 2025-10-01 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
881 -0.4%
14.01
US$12,343 		881 -0.4% 14.01 US$12,343
2025-10-01 2025-10-01 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
1,700 -9.0%
13.99
US$23,783 		1,700 -9.0% 13.99 US$23,783
2025-10-01 2025-09-29 PlS Planned sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
419 -0.2%
14.01
US$5,870 		419 -0.2% 14.01 US$5,870
2025-10-01 2025-09-29 PlS Planned sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
100 -0.5%
14.00
US$1,400 		100 -0.5% 14.00 US$1,400
2025-09-29 2025-09-29 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
100
14.03
US$1,403 		100 14.03 US$1,403
2025-09-29 2025-09-29 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
419
14.01
US$5,870 		419 14.01 US$5,870
2025-09-29 2025-09-25 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
6,790
14.09
US$95,662 		6,790 14.09 US$95,662
2025-09-26 2025-09-25 S Sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
6,790 -3.2%
14.09
US$95,671 		6,790 -3.2% 14.09 US$95,671
2025-09-26 2025-09-25 S Sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
10,900 -36.5%
14.05
US$153,182 		10,900 -36.5% 14.05 US$153,182
2025-09-25 2025-09-25 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
10,900
13.78
US$150,202 		10,900 13.78 US$150,202
2025-09-26 2025-09-24 S Sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
2,581 -1.2%
13.99
US$36,108 		2,581 -1.2% 13.99 US$36,108
2025-09-26 2025-09-24 S Sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
1,500 -4.8%
14.00
US$20,993 		1,500 -4.8% 14.00 US$20,993
2025-09-25 2025-09-24 PrS Proposed sale
2.8
Quang X. Pham

Officer

Officer
6,790
14.09
US$95,662 		6,790 14.09 US$95,662
2025-09-24 2025-09-24 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
1,500
13.68
US$20,520 		1,500 13.68 US$20,520
2025-09-24 2025-09-24 PrS Proposed sale
2.8
Quang Pham

Officer

Officer
2,581
13.99
US$36,108 		2,581 13.99 US$36,108
2025-08-29 2025-08-28 S Sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
1,193 -0.6%
13.99
US$16,690 		1,193 -0.6% 13.99 US$16,690
2025-08-29 2025-08-28 S Sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
400 -1.3%
14.00
US$5,600 		400 -1.3% 14.00 US$5,600
2025-08-28 2025-08-28 PrS Proposed sale
2.8
Pham Quang X

Officer

Officer
1,193
13.86
US$16,541 		1,193 13.86 US$16,541
2025-08-28 2025-08-28 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
400
13.93
US$5,572 		400 13.93 US$5,572
2025-08-29 2025-08-27 S Sale
2.8
Pham Quang X

CEO and Chairman

Executive Director Large shareholder
3,836 -1.8%
13.99
US$53,666 		3,836 -1.8% 13.99 US$53,666
2025-08-29 2025-08-27 S Sale
2.3
Szot Matthew K

Chief Financial Officer

Officer
1,600 -4.8%
14.00
US$22,392 		1,600 -4.8% 14.00 US$22,392
2025-08-27 2025-08-27 PrS Proposed sale
2.8
Pham Quang X

Officer

Officer
3,836
13.94
US$53,456 		3,836 13.94 US$53,456
2025-08-27 2025-08-27 PrS Proposed sale
2.8
Pham Quang X

Officer

Officer
30,600
13.99
US$428,094 		30,600 13.99 US$428,094
2025-08-27 2025-08-27 PrS Proposed sale
2.3
MATTHEW SZOT

Officer

Officer
1,600
13.75
US$22,000 		1,600 13.75 US$22,000
2023-10-06 2023-10-05 B Purchase
2.8
MURPHY JOHN RAYMOND
Non-Executive Director
2,669 +0.4%
0.69
US$1,842 		2,669 +0.4% 0.69 US$1,842

See older Cadrenal Therapeutics Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Cadrenal Therapeutics Inc history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Cadrenal Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America